[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Forte Biosciences Inc (FBRX)

Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 296,049
  • Shares Outstanding, K 13,886
  • Annual Sales, $ 0 K
  • Annual Income, $ -69,380 K
  • EBIT $ -77 M
  • EBITDA $ -77 M
  • 60-Month Beta 2.85
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.01

Options Overview Details

View History
  • Implied Volatility 210.56% (+3.53%)
  • Historical Volatility 67.70%
  • IV Percentile 80%
  • IV Rank 59.09%
  • IV High 291.19% on 11/06/25
  • IV Low 94.11% on 07/28/25
  • Expected Move (DTE 15) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 55
  • Put/Call OI Ratio 4.43
  • Today's Open Interest 1,125
  • Open Int (30-Day) 666
  • Expected Range 21.24 to 21.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-1.08
  • Number of Estimates 1
  • High Estimate $-1.08
  • Low Estimate $-1.08
  • Prior Year $-0.96
  • Growth Rate Est. (year over year) -12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.51 +34.88%
on 06/08/26
22.39 -6.54%
on 06/30/26
+2.75 (+15.10%)
since 06/02/26
3-Month
15.51 +34.88%
on 06/08/26
35.80 -41.56%
on 04/09/26
-4.66 (-18.22%)
since 04/02/26
52-Week
9.10 +129.89%
on 08/06/25
35.80 -41.56%
on 04/09/26
+7.08 (+51.16%)
since 07/02/25

Most Recent Stories

More News
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the issuance...

FBRX : 20.92 (-1.88%)
Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update

FB102 Received Fast Track Designation in Celiac Disease

FBRX : 20.92 (-1.88%)
Forte Biosciences Announces Pricing of $150 Million Public Offering

Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the pricing of a public offering of 5,709,936 shares...

FBRX : 20.92 (-1.88%)
Forte Biosciences Announces Proposed Public Offering

Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced that it has commenced an underwritten public offering...

FBRX : 20.92 (-1.88%)
Forte Biosciences, Inc. Announces 2025 Results and Provides Update

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its full year...

FBRX : 20.92 (-1.88%)
Forte Biosciences Faces Critical Test as Losses Expected to Widen Sharply

Barchart Research What to Expect from FBRX Earnings FBRX Generated March 26, 2026 Current Price $27.01 EPS Estimate $-1.42 Consensus Rating Strong Buy Average Move 6.02% Forte Biosciences Faces Critical...

FBRX : 20.92 (-1.88%)
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody...

FBRX : 20.92 (-1.88%)
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody...

FBRX : 20.92 (-1.88%)
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced it will be...

FBRX : 20.92 (-1.88%)
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody...

FBRX : 20.92 (-1.88%)

Business Summary

Forte Biosciences Inc. is a clinical stage, dermatology company. It engages in developing biotherapeutic, FB-401, for the treatment of inflammatory skin diseases which is in clinical stage. Forte Biosciences Inc., formerly known as Tocagen Inc., is based in Sherman Oaks, California.

See More

Key Turning Points

3rd Resistance Point 23.11
2nd Resistance Point 22.43
1st Resistance Point 21.87
Last Price 20.92
1st Support Level 20.64
2nd Support Level 19.96
3rd Support Level 19.40

See More

52-Week High 35.80
Fibonacci 61.8% 25.60
Fibonacci 50% 22.45
Last Price 20.92
Fibonacci 38.2% 19.30
52-Week Low 9.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.